Latest Insider Transactions at Pmv Pharmaceuticals, Inc. (PMVP)
This section provides a real-time view of insider transactions for Pmv Pharmaceuticals, Inc. (PMVP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PMV Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PMV Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 28
2021
|
David Henry Mack President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
204
+1.58%
|
$0
$0.53 P/Share
|
|
Jun 21
2021
|
Arnold J Levine |
SELL
Open market or private sale
|
Direct |
3,500
-0.41%
|
$115,500
$33.66 P/Share
|
|
Jun 14
2021
|
Euclidean Capital LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
44,419
-0.98%
|
$1,510,246
$34.11 P/Share
|
|
Jun 11
2021
|
Euclidean Capital LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
21,977
-0.48%
|
$725,241
$33.8 P/Share
|
|
Jun 10
2021
|
Euclidean Capital LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
20,633
-0.45%
|
$660,256
$32.68 P/Share
|
|
Jun 09
2021
|
Euclidean Capital LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
39,638
-0.86%
|
$1,308,054
$33.64 P/Share
|
|
Jun 08
2021
|
Euclidean Capital LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
31,724
-0.68%
|
$1,046,892
$33.38 P/Share
|
|
Jun 07
2021
|
Euclidean Capital LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
30,721
-0.68%
|
$1,013,793
$33.62 P/Share
|
|
Jun 07
2021
|
Leila Alland Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,000
-82.91%
|
$132,000
$33.7 P/Share
|
|
Jun 07
2021
|
Leila Alland Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+50.0%
|
$12,000
$3.9 P/Share
|
|
Jun 04
2021
|
Winston Kung COO, CFO |
SELL
Open market or private sale
|
Direct |
4,500
-73.77%
|
$148,500
$33.75 P/Share
|
|
Jun 04
2021
|
Winston Kung COO, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,500
+42.45%
|
$13,500
$3.22 P/Share
|
|
Jun 01
2021
|
Richard A. Heyman |
SELL
Open market or private sale
|
Indirect |
3,900
-91.47%
|
$128,700
$33.51 P/Share
|
|
Jun 01
2021
|
Richard A. Heyman |
BUY
Exercise of conversion of derivative security
|
Indirect |
3,900
+50.0%
|
$1,271,400
$326.97 P/Share
|
|
May 28
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
5,100
-0.25%
|
$178,500
$35.8 P/Share
|
|
May 26
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
7,487
-0.37%
|
$262,045
$35.66 P/Share
|
|
May 25
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
8,518
-0.41%
|
$298,130
$35.91 P/Share
|
|
May 24
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
22,095
-1.06%
|
$795,420
$36.03 P/Share
|
|
May 21
2021
|
David Henry Mack President and CEO |
SELL
Open market or private sale
|
Direct |
6,207
-71.53%
|
$217,245
$35.71 P/Share
|
|
May 21
2021
|
David Henry Mack President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,207
+41.7%
|
$0
$0.53 P/Share
|
|
May 21
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
19,774
-0.94%
|
$692,090
$35.84 P/Share
|
|
May 20
2021
|
David Henry Mack President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,793
+43.83%
|
$0
$0.53 P/Share
|
|
May 20
2021
|
David Henry Mack President and CEO |
SELL
Open market or private sale
|
Direct |
7,793
-75.93%
|
$272,755
$35.6 P/Share
|
|
May 20
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
2,911
-0.14%
|
$101,885
$35.65 P/Share
|
|
May 20
2021
|
Arnold J Levine |
SELL
Open market or private sale
|
Direct |
3,500
-0.41%
|
$119,000
$34.13 P/Share
|
|
May 10
2021
|
Interwest Partners X LP > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
6,446
+31.24%
|
-
|
|
May 10
2021
|
Interwest Partners X LP > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
5,000
-100.0%
|
-
|
|
May 10
2021
|
Interwest Partners X LP > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
500,000
-9.14%
|
-
|
|
May 10
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
1,787
-0.08%
|
$62,545
$35.67 P/Share
|
|
May 07
2021
|
Leila Alland Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,000
-98.03%
|
$140,000
$35.15 P/Share
|
|
May 07
2021
|
Leila Alland Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+50.0%
|
$12,000
$3.9 P/Share
|
|
May 05
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
600
-0.03%
|
$21,000
$35.64 P/Share
|
|
May 03
2021
|
Winston Kung COO, CFO |
SELL
Open market or private sale
|
Direct |
4,500
-73.77%
|
$148,500
$33.75 P/Share
|
|
May 03
2021
|
Winston Kung COO, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,500
+42.45%
|
$13,500
$3.22 P/Share
|
|
Apr 12
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
3,903
-0.06%
|
$124,896
$32.09 P/Share
|
|
Apr 09
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
25,763
-0.6%
|
$875,942
$34.32 P/Share
|
|
Apr 08
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
33,322
-0.77%
|
$1,132,948
$34.03 P/Share
|
|
Apr 07
2021
|
Leila Alland Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,000
-99.65%
|
$136,000
$34.14 P/Share
|
|
Apr 07
2021
|
Leila Alland Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+50.0%
|
$12,000
$3.9 P/Share
|
|
Apr 07
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
24,457
-0.56%
|
$831,538
$34.19 P/Share
|
|
Apr 06
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
78,657
-1.74%
|
$2,674,338
$34.26 P/Share
|
|
Apr 05
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
48,193
-1.04%
|
$1,590,369
$33.74 P/Share
|
|
Apr 01
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
12,435
-0.53%
|
$397,920
$32.94 P/Share
|
|
Mar 31
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
33,626
-0.48%
|
$1,076,032
$32.15 P/Share
|
|
Mar 30
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
22,483
-0.47%
|
$696,973
$31.01 P/Share
|
|
Mar 29
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
2,174
-0.05%
|
$69,568
$32.38 P/Share
|
|
Mar 26
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
35,268
-1.45%
|
$1,163,844
$33.44 P/Share
|
|
Mar 25
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
66,327
-0.89%
|
$2,188,791
$33.98 P/Share
|
|
Mar 24
2021
|
Thilo Schroeder Director |
SELL
Open market or private sale
|
Indirect |
34,881
-0.35%
|
$1,290,597
$37.04 P/Share
|
|
Mar 24
2021
|
Interwest Partners X LP > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
12,892
+50.0%
|
-
|